Cheng's studies are providing more information about whether accessory proteins
, when ingested with food, make natural toxin more--or less--bioavailable than purified toxin.
25, 2011 /PRNewswire/ -- Merz Pharmaceuticals, LLC, today announced that data from studies evaluating the dosing and adverse event profiles of Xeomin (incobotulinumtoxinA), a botulinum toxin type A free from accessory proteins, in the treatment of blepharospasm (eyelid spasms) will be presented at the 115th Annual Meeting of the American Association of Ophthalmology (AAO) in Orlando, Fla.
In nature, Clostridium botulinum produces botulinum toxin in association with ancillary accessory proteins.
Data Indicate that XEOMIN, a Botulinum Toxin Type A Free From Accessory Proteins, Provides Sustained Efficacy For Up to 88 Weeks Among Both Toxin-Naive and Previously-Treated Cervical Dystonia Patients
XEOMIN (incobotulinumtoxinA), is manufactured using a proprietary process that isolates the therapeutic component and eliminates accessory proteins.
In nature, Clostridium botulinum produces the toxin in association with ancillary accessory proteins
5, 2010 /PRNewswire/ -- Merz Pharmaceuticals announced today that data from stability and clinical studies evaluating Xeomin (incobotulinumtoxinA), a botulinum toxin type A free from accessory proteins, will be presented at the 71st Annual Assembly of the American Academy of Physical Medicine and Rehabilitation (AAPM&R) in Seattle, Wash.
In nature, Clostridium botulinum produces the 150 kDa neurotoxin molecule with accessory proteins, resulting in a complex with a molecular weight of 900 kDa.
XEOMIN is a botulinum toxin type A that is free from accessory proteins
HDAC inhibitors, a new class of cancer drugs, work by controlling how tightly DNA is wound around accessory proteins
Clathrin- and AP-2-Binding Sites in HIP1 Uncover a General Assembly Role of Endocytic Accessory Proteins